Intelligent Investor
Intelligent Investor
  1. Home
  2. Research & Advice
  3. Research Tools
  4. Shares
  5. ResMed Inc. (RMD)
Sign up for free Sign up for free Sign up for free

ResMed Inc. (ASX: RMD) - Share Price and Research

Current share price for RMD : $36.750 0.18 (0.49%)+

ResMed Inc.(RMD), an ASX-listed company, pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases. and lower costs for consumers and healthcare systems in more than 140 countries.

The Intelligent Investor Australian Equity Income Fund (ASX:INIF), Intelligent Investor Ethical Share Fund (ASX:INES), Intelligent Investor Australian Equity Growth Fund (ASX:IIGF) owns shares in ResMed Inc. (ASX: RMD)

RMD General Information +

ASX Code RMD
Website http://www.resmed.com
Industry/Sector Health Care Equipment
Market Cap ($M) 53,868
RMD Share Price $36.750
Day High $36.760
Day Low $36.180
Last Close $36.930
RMD Share Price Movement $0.18 ( 0.49% )
Prices as at 16:41, 29 Apr 2025
+Security prices are delayed by at least 20 minutes and are indicative only.

Recommendation

ResMed Inc. - RMD
Unlock recommendation
BUY
below Recommendation Locked
HOLD
up to Recommendation Locked
SELL
above Recommendation Locked
Current price
$36.75 at 16:41 (29 April 2025)
Price at review
$36.08 at (28 April 2025)
Max Portfolio Weighting
Maximum Portfolio Weighting Locked
Business Risk
Business Risk Locked
Share Price Risk
Share Price Risk Locked
All Prices are in AUD ($)
Upsell Banner

RMD Related Research

Stock Take: A Whole New World

Angus Donohoo and Graham Witcomb join Nick Cummings on this week's episode of Stock Take to discuss investment opportunities during a market downturn, the new world and AI, ResMed, and more!
Intelligent Investor

09 Aug 2024
·
Published by Intelligent Investor

ResMed Inc. (RMD) Upcoming Dividends & Yields

Distribution Type Dividend Franking Ex-dividend date Payment date Current Price+ Price 7D Avg Dividend Yield
Result 5.8¢ 0% 7 May 2025 12 Jun 2025 $36.750 $33.610 0.88%
Result 5.81¢ 0% 12 Feb 2025 20 Mar 2025 $36.750 $33.610 0.88%
Result 5.53¢ 0% 6 Nov 2024 12 Dec 2024 $36.750 $33.610 0.88%

See all dividends from ResMed Inc. (RMD) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

ResMed Inc. (RMD) price-sensitive announcements

RMD - Form 10-Q for the Quarter Ended March 31, 2025
For the quarter ended March 31, 2025, ResMed Inc. reported a net income of $365.0 million,
ResMed Inc. (RMD)
28 Apr 2025 | 8:08 AM
RMD - Dividend/Distribution - RMD
ResMed Inc has announced a dividend of USD 0.053 per share for holders of Chess Depositary
ResMed Inc. (RMD)
24 Apr 2025 | 8:18 AM
RMD - Resmed Announces Results for the Third Quarter of FY2025
ResMed Inc. reported its financial results for the third quarter of Fiscal Year 2025, show
ResMed Inc. (RMD)
24 Apr 2025 | 8:17 AM
RMD - Form 10-Q for the Quarter Ended December 31, 2024
For the quarter ended December 31, 2024, ResMed Inc. reported a net revenue increase of 10
ResMed Inc. (RMD)
3 Feb 2025 | 8:21 AM

See more price-sensitive ASX announcements or use our ASX Announcements tool to search for announcements across all ASX-listed securities.

ResMed Inc. (RMD) Recent ASX Announcements

Company Sector Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
ResMed Inc. (RMD)
CDI 10:1 FOREIGN EXEMPT NYSE
 Health Care $53,868 Form 10-Q for the Quarter Ended March 31, 2025 28 Apr 2025 8:08AM $36.080 $36.750 risen by 1.86%
ResMed Inc. (RMD)
CDI 10:1 FOREIGN EXEMPT NYSE
 Health Care $53,868 Dividend/Distribution - RMD 24 Apr 2025 8:18AM $33.250 $36.750 risen by 10.53%
ResMed Inc. (RMD)
CDI 10:1 FOREIGN EXEMPT NYSE
 Health Care $53,868 Resmed Announces Results for the Third Quarter of FY2025 24 Apr 2025 8:17AM $33.250 $36.750 risen by 10.53%
ResMed Inc. (RMD)
CDI 10:1 FOREIGN EXEMPT NYSE
 Health Care $53,868 Statement of changes in beneficial ownership of securities 15 Apr 2025 8:25AM $33.610 $36.750 risen by 9.34%
ResMed Inc. (RMD)
CDI 10:1 FOREIGN EXEMPT NYSE
 Health Care $53,868 Notice of Proposed Sale of Securities 9 Apr 2025 8:20AM $34.920 $36.750 risen by 5.24%
ResMed Inc. (RMD)
CDI 10:1 FOREIGN EXEMPT NYSE
 Health Care $53,868 Notice of Proposed Sale of Securities 8 Apr 2025 8:21AM $33.460 $36.750 risen by 9.83%

RMD Financial Summary

Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2026F $2,235.46 $151.45 10.20% 25.03 44.61 1.18% 0.0%
2025F $2,028.91 $137.46 16.70% 27.58 34.38 0.91% 0.0%
2024A $1,737.52 $117.75 23.10% 23.39 30.04 1.09% 0.0%

RMD Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2024 A 2025 F 2026 F 2024 A 2025 F 2026 F 2024 A 2025 F 2026 F
Cochlear (COH) $17,305M 0.2705 0.0861 0.1023 44.9766 41.4116 37.5678 1.55% 1.68% 1.86%
Fisher & Paykel Hlth (FPH) $18,520M -0.4850 1.5943 0.2488 152.3878 58.7393 47.0369 1.21% 1.23% 1.38%
ResMed (RMD) $21,402M -0.8795 10.5077 0.1024 324.7525 28.2206 25.5995 0.82% 0.86% 1.01%

RMD Market Comparison

Earnings P/E Ratio P/B Ratio P/E Growth
Company 0.67 34.30 7.39 0.13
Market 0.58 17.80 1.42 1.03
Sector 0.79 25.80 1.84 1.28

RMD Directors

Name Position Start Date
Mr Michael J Farrell Chief Executive Officer, Executive Director 1 Mar 2013
Mr Ronald R Taylor Non-Executive Director 25 Jan 2005
Mr Richard Sulpizio Non-Executive Director 30 Aug 2005
Ms Carol Burt Non-Executive Director 11 Aug 2014
Ms Karen Ruth Drexler Non-Executive Director 17 Nov 2017
Mr Jan De Witte Non-Executive Director 16 May 2019
Ms Harjit Gill Non-Executive Director 15 Nov 2018
Mr John Hernandez Non-Executive Director 19 Nov 2021
Mr Desney Tan Non-Executive Director 19 Nov 2021
Mr Christopher DelOrefice Non-Executive Director 19 Aug 2024
Dr Peter Craig Farrell Non-Executive Director, Non-Executive Chairman 1 Jul 2002

ResMed Inc. (RMD) Changes in Directors' Interest & Trades

Date of change Director Buy/Sell Security Type Qty Trade Price Value
2 Jul 2024 ROBERTS, Christopher Issued Options 12,000 $50.950 $611,400.000
19 Aug 2011 FARRELL, Peter Sell Direct Shares 200,000 $0.000
17 Aug 2011 FARRELL, Peter Issued Related Securities 28,571 $0.000

See all changes in directors' interest & trades for ResMed Inc. (RMD) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

RMD Management

Name Position
Brett A. Sandercock Chief Financial Officer

RMD Calendar of Events

Date Event
11 August 2025 Report (Annual)
12 June 2025 Div Pay Date
08 May 2025 Books Close
07 May 2025 Div Ex Date

FAQs about ResMed Inc. (RMD)

ResMed Inc.'s (RMD) current share price is $36.75. This constitutes a price movement of 9.34% when compared to the share price 7 days ago and is -9.26% below RMD's 12-month high of $40.50 per share. Prices are delayed by at least 20 minutes.

Relative to the previous close share price of $36.93, ResMed Inc.'s (RMD) current share price of $36.75 constitutes a movement of -$0.18 or -0.49%. ResMed Inc.'s (RMD) share price movement is 9.34% when compared to 7 days ago and is -9.26% below RMD's 52-week high of $40.50.

ResMed Inc.'s (RMD) 52-week high is $40.50 which was reached on 30 Jan 2025. Relative to this, RMD's current share price of $36.75 constitutes a -$3.75 or -9.26% drop since that high of $40.50 per RMD share.

ResMed Inc.'s (RMD) 52-week low is $27.65 which was reached on 26 Jun 2024. Relative to this, RMD's current share price of $36.75 constitutes a $9.10 or 32.91% gain since that low of $27.65 per RMD share.

Over the last 12 months, ResMed Inc. (RMD) has a daily average trading volume of 1,411,378 RMD shares per day.

ResMed Inc. (RMD) has a current dividend yield of n/a this year. Last year's dividend yield was 1%. The dividend yield for RMD is a ratio that tells you the percentage of ResMed Inc.'s (RMD) share price that it pays out in dividends each year.

ResMed Inc. (RMD) last dividend payment was $0.06 per share and was paid on 20 Mar 2025. This last RMD dividend included 0% franking. The next dividend payment for ResMed Inc. (RMD) is due on 12 Jun 2025.

ResMed Inc. (RMD) pays its next dividend on 12 Jun 2025 and goes ex-dividend date on 7 May 2025. ResMed Inc.'s (RMD) last dividend was $0.06, with franking of 0%, and was paid on 20 Mar 2025.

ResMed Inc.'s (RMD) next ex-dividend date is 7 May 2025. ResMed Inc.'s (RMD) ex-dividend date refers to the cut-off date for investors to buy RMD shares and still be entitled to receive its upcoming dividend. On and from this ex-dividend date, the right to receive the next dividend payment from ResMed Inc. (RMD) is no longer included with the purchase of RMD shares.

ResMed Inc. (RMD) has a franking level of 0%. Franking represents the tax ResMed Inc. (RMD) has already paid on any profit it distributes to shareholders as a dividend. ResMed Inc. (RMD) pays its next dividend on 12 Jun 2025.

ResMed Inc. (RMD) will release its next Annual Report on 11 August 2025. ResMed Inc.'s (RMD) last annual report was released on 12 Aug 2024. Click here to view ResMed Inc.'s (RMD) last annual report.

ResMed Inc. (RMD) is classified as Health Care. Other companies in this sector include CSL Limited (CSL), Sigma Healthcare Limited (SIG), Pro Medicus Limited (PME), and Fisher & Paykel Healthcare Corporation Limited (FPH).

The price-to-earnings (P/E) ratio for ResMed Inc. (RMD) is 34.3. The price-to-earnings ratio, also known as P/E ratio, P/E, or PER, is the ratio of ResMed Inc.'s (RMD) share price to its earnings per RMD share.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.